ANTIPHOSPHOLIPID ANTIBODIES AND PREGNANCY LOSS

被引：29

作者：

OUT, HJ

BRUINSE, HW

DERKSEN, RHWM

机构：

[1] Department of Internal Medicine, Division of Immunopathology

[2] Department of Obstetrics and Gynaecology, University Hospital Utrecht, 3508 GA Utrecht

来源：

HUMAN REPRODUCTION | 1991年 / 6卷 / 06期

关键词：

ABORTION; ANTICARDIOLIPIN ANTIBODIES; ANTIPHOSPHOLIPID ANTIBODY; LUPUS ANTICOAGULANT; PREGNANCY;

D O I：

10.1093/oxfordjournals.humrep.a137446

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Anti-phospholipid antibodies such as the lupus anticoagulant and anti-cardiolipin antibodies, are antibodies directed at negatively charged phospholipids and have received much attention in the last decade. Their presence has been associated with a thrombotic tendency, leading to a variety of clinical symptoms. In the pregnant woman, the presence of these antibodies may have consequences for management, since retrospective reports have established a correlation between the lupus anticoagulant or anti-cardiolipin antibodies with intrauterine fetal death, probably due to placental thrombosis. This article reviews current knowledge on anti-phospholipid antibodies in relation to pregnancy loss, focusing on clinical aspects.

引用

页码：889 / 897

页数：9

共 107 条

[1]

Alarcon-Segovia D., Pathogenetic potential of antiphospholipid antibodies, J. Rheumatol, 15, pp. 890-893, (1988)

[2]

Asherson R.A., Khamashta M.A., Ordi-Ros J., Derksen R.H.W.M., Machin S.J., Barquinero J., Out H.J., Harris E.N., Vilardell-Torres M., Hughes G.R.V., The ‘primary’ Antiphospholipid Syndrome: Major Clinical and Serological Features. Medicine, 68, pp. 366-374, (1989)

[3]

Barbui T., Radici E., Cortelazzo S., Rossi E., Galli M., Finazzi G., Parazzini F., Antiphospholipid antibodies in early repeated abortions: A case-controlled study, Fertil. Steril, 50, pp. 589-592, (1988)

[4]

Boey M.L., Colaco C.B., Gharavi A.E., Elkon K.B., Loizou S., Hughes G.R.V., Thrombosis in systemic lupus erythematosus: Striking association with the presence of circulating lupus anticoagulant, Br.Med. J, 278, pp. 1021-1023, (1983)

[5]

Bowie E.J.W., Thompson J.H., Pascuzzi C.A., Owen C.A., Thrombosis in systemic lupus erythematosus despite circulating anticoagulants, J. Lab. Clin. Med, 62, pp. 416-430, (1963)

[6]

Branch D.W., Scott J.R., Kochenour N.K., Hershgold E., Obstetric complications associated with the lupus anticoagulant, N. Engl. J. Med, 313, pp. 1322-1326, (1985)

[7]

Branch D.W., Res R., Digre K.B., Rote N.S., Scott J.R., The association of antiphospholipid antibodies with severe preeclampsia, Obstet. Gynecol, 73, pp. 541-545, (1989)

[8]

Branch D.W., Dudley D.J., Mitchell M.D., Creighton K.A., Abbott T.M., Hammond E.H., Daynes R.A., Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss, Am. J. Obstet. Gynecol, 163, pp. 210-216, (1990)

[9]

Campbell J.M., Tate G., Scott J.S., The use of warfarin in pregnancy complicated by circulating lupus anticoagulant

[10]

a technique for monitoring, Eur. J. Obstet. Gynecol. Reprod. Biol, 29, pp. 27-32, (1988)

← 1 2 3 4 5 6 7 8 9 10 →